Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:170–80
F. DebruyneDepartment of Urology, Academic Hospital Nijmegen, Geert Grooteplein Zuid 16, 426 Afdeling Urologie, 6500 Nijmegen, The NetherlandsA A GresD. ArustamovCenter of Urology, Ministry of Health of Republic of Uzbekistan, 700 109 Tashkent, Uzbekistan
ABI
Аннотация
Аннотация мавжуд эмас.
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос6 та фойдаланилган манба